The adoption of new European regulations on medical devices and in-vitro diagnostics has triggered major changes in the Medtech sector, resulting in pressure on employees in Clinical Affairs, Regulatory Affairs and Quality Assurance – CA/RA/QA.

Countries in the Gulf, Asia and South America now have requirements that are as complex as those in Europe or the USA. Exporting to these countries is therefore a challenge for Swiss firms.


Training objectives

Faced with the evolution of CA/RA/QA functions, the aim is to develop a broad range of technical and human skills in order to evolve towards the organisation’s decision-making centres and play a key role in maintaining the company’s competitiveness and sustainability.

The CAS CARAQA develops the following skills:

  • Optimal preparation for MDR 2017/745 and IVDR 2017/746 regulatory changes
  • Strategic planning and management of clinical evaluations, investigations under ISO 14155 and IVD performance studies
  • Strategic and tactical communication for interaction with Notified Bodies and National Competent Authorities and to deal with crisis situations
  • Management and engineering support during new product development projects
  • Leadership in the deployment and maintenance of Quality Management Systems under ISO 13485 and US QSR
  • Structuring of supply chain, production and marketing structuring
  • Technical expertise in key subjects such as risk management, biocompatibility, usability, and software validation, according to current standards

In collaboration with Medidee, the School of Life Sciences FHNW offers a unique training opportunity for Medtech professionals facing the current major regulatory challenges. The CAS-Program fulfils the requirements of article 15 of MDR / IVDR.

  • January 12, 2021 @ 9:00 am
  • July 6, 2021
  • Switzerland
Event starts in
  • 00

  • 00

  • 00


Muttenz, Switzerland

Contact Form